Skip to main content
. 2018 Oct 16;9(81):35251–35265. doi: 10.18632/oncotarget.25834

Table 5b. FDG-PET responses in patients receiving SRT after first-line line chemotherapy (18 patients).

FDG-PET response
CMR PMR SMD PMD
Sites of disease
 Lung 10 2 6 2 0
 Liver 0 0 0 0 0
 Lung and liver 4 0 2 1 1
 Presence of LN metastases 4 0 2 0 2

CMR: complete metabolic response; PMR: partial metabolic response; SMD: stable metabolic disease; PMD: progressive metabolic disease.

*All PMDs were attributable to new lesions distant form the irradiated sites.